Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali has claimed that an Ayurvedic medicine developed by the company has been able to cure COVID-19 patients within 5-14 days.
“We appointed a team of scientists after COVID-19 outbreak. Firstly, the simulation was done and compounds were identified which can fight the virus and stop its spread in the body. Then, we conducted a clinical case study on hundreds of positive patients and we have got 100% favourable results,” Balkrishna said.
“We are not talking about an immunity booster. We are talking about a cure,” said Acharya Balkrishna, managing director of Patanjali.
Balkrishna on Saturday said that a trial was conducted on hundreds of COVID-19 patients and that the medicine has yielded “100% favourable results”. However, there has been no statement regarding the claim by the Health Ministry or ICMR so far.
“We can say that the cure for COVID is possible through Ayurveda,” he claimed, adding that the company is now conducting controlled clinical trials and will release evidence in less than a week.
More than 100 potential COVID-19 vaccines are in various stages of development around the world. Among front runners currently in human trials are the COVID-19 vaccines being developed by AstraZeneca, Pfizer, BioNtech, Johnson & Johnson, Merck, Moderna, Sanofi and China’s CanSino Biologics.
Meanwhile, the Maharashtra government has approved the use of homeopathy medicine Arsenic Album 30 for the general population as a prophylactic against COVID-19 and as an immunity booster. A task force set up by state government has also come up with a list of Unani and Ayurvedic medicines like Agastya Haritaki, Ayush 64 and even sesame oil, as measures against COVID-19.
In 2014, Prime Minister Narendra Modi had created the Ministry of AYUSH to promote and regulate ayurvedic remedies and yoga. It is the country’s indigenous medicine ministry.
Last month, Union minister Shripad Y Naik had said India is working on four traditional medicine formulations to treat the coronavirus. More than 100 potential COVID-19 candidate vaccines are now under development by biotech and research teams around the world, and at least six of these are in preliminary testing in people in what is known as Phase 1 clinical trials.
India is the fourth-worst hit country in the world, with cases rising sharply each day. It reported a record single-day jump in cases on Sunday with 11,929 new infections. The total number of cases has risen to 3,20,922.